Feed

APNHF

Aspen Pharmacare Holdings Limited

APNHF · OTC

$8.90 +0.00% (+$0.00)

Bulios Fair Price

$6.75

24.1% downside

Current Price

$8.9

Undervalued Fair Value Overvalued

According to Bulios Fair Price, APNHF is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Strong

7/9

Valuation

N/A

P/E N/A

EV/EBITDA N/A

P/S N/A

Growth

28 /100

Declining

Rev. growth 3.95%

FCF growth 66.13%

Book val. growth 6.17%

Profitability

N/A

Gross margin N/A

Net margin N/A

Op. margin N/A

Quality

N/A

ROIC N/A

ROE N/A

ROA N/A

Debt

N/A

Debt/Equity N/A

Current ratio N/A

Int. coverage N/A

Stability

46 /100

Moderate

Beta 0.34x

Rev. volatility 6.52%

EPS volatility 62.26%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about APNHF

Online

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Stephen Bradley Saad

Employees

9,557

Headquarters

Durban

Upcoming events

07 OCT

Ex-Dividend

Ex-dividend date

12 OCT

Dividend Payment

Payment date

11 MAR

Earnings

Upcoming earnings report

157d

⌘ K

StockBot Live

Market situation Wall Street

US stocks slip on Middle East fears as Europe stays mixed

S&P 500 -0.17% and Nasdaq -0.24% fall on Iran fears. CAC 40 drops -1.04% as Schneider sinks.

Ask about this

StockBot knows 80,000+ stocks worldwide